{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:54:09Z","timestamp":1784296449405,"version":"3.55.0"},"reference-count":158,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21AI121700"],"award-info":[{"award-number":["R21AI121700"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI050875"],"award-info":[{"award-number":["R01AI050875"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ygyno.2021.02.004","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T18:20:56Z","timestamp":1612981256000},"page":"314-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers"],"prefix":"10.1016","volume":"161","author":[{"given":"Maryam","family":"Hashemipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homa","family":"Boroumand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samaneh","family":"Mollazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vida","family":"Tajiknia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Nourollahzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Rohani Borj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Pourghadamyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Rahimian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Hamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-020-09593-6","article-title":"Years of life lost due to premature death and their trends in people with malignant neoplasm of female genital organs in Shanghai, China during 1995\u20132018: a population based study","volume":"20","author":"Luo","year":"2020","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.ygyno.2021.02.004_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.annonc.2019.11.004","article-title":"Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature","volume":"31","author":"Kalliala","year":"2020","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.02.004_bb0015","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.ygyno.2021.02.004_bb0020","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1177\/0193945919846901","article-title":"Quality of life and supportive care needs of gynecologic cancer survivors","volume":"41","author":"Reb","year":"2019","journal-title":"West. J. Nurs. Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2021.02.004_bb0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12912-019-0355-x","article-title":"Gynecological cancer inpatients need more supportive nursing care than outpatients: a comparative study","volume":"18","author":"Mawardika","year":"2019","journal-title":"BMC Nurs."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.maturitas.2011.06.013","article-title":"Sexuality after gynaecological cancer: a review of the material, intrapsychic, and discursive aspects of treatment on women\u2019s sexual-wellbeing","volume":"70","author":"Gilbert","year":"2011","journal-title":"Maturitas."},{"issue":"1225","key":"10.1016\/j.ygyno.2021.02.004_bb0035","article-title":"Long Non-coding RNA DANCR as an emerging therapeutic target in human cancers","volume":"9","author":"Jin","year":"2019","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.ygyno.2021.02.004_bb0040","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/cas.13342","article-title":"Long non-coding RNAs as an epigenetic regulator in human cancers","volume":"108","author":"Kondo","year":"2017","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13046-020-01622-x","article-title":"Non-coding RNAs in cancer: platforms and strategies for investigating the genomic \u201cdark matter\u201d","volume":"39","author":"Grillone","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.ygyno.2021.02.004_bb0050","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.ygyno.2021.02.004_bb0055","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1111\/cas.13642","article-title":"Emerging roles of long non-coding RNA in cancer","volume":"109","author":"Sanchez Calle","year":"2018","journal-title":"Cancer Sci."},{"issue":"9","key":"10.1016\/j.ygyno.2021.02.004_bb0060","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3390\/cells8091015","article-title":"Long non-coding RNA in the pathogenesis of cancers","volume":"8","author":"Chi","year":"2019","journal-title":"Cells."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12964-020-00555-4","article-title":"TGF-\u03b2 and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus","volume":"18","author":"Yousefi","year":"2020","journal-title":"Cell Commun. Signal."},{"issue":"4","key":"10.1016\/j.ygyno.2021.02.004_bb0070","doi-asserted-by":"crossref","first-page":"342","DOI":"10.5582\/bst.2018.01181","article-title":"Long non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in gynecologic cancers","volume":"12","author":"Lin","year":"2018","journal-title":"Biosci. Trends."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0671-2","article-title":"Dysregulated expression of long noncoding RNAs in gynecologic cancers","volume":"16","author":"Hosseini","year":"2017","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2021.02.004_bb0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/cei.12974","article-title":"Exosomes carrying immunoinhibitory proteins and their role in cancer","volume":"189","author":"Whiteside","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1049-4","article-title":"Exosomes promote pre-metastatic niche formation in ovarian cancer","volume":"18","author":"Feng","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-46221-9","article-title":"Expression of small heat shock proteins in exosomes from patients with gynecologic cancers","volume":"9","author":"Wyciszkiewicz","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0095","series-title":"Exosomes Could Offer the Benefits of Mesenchymal Stem Cell Therapies without the Drawbacks","author":"Asgarpour","year":"2020"},{"issue":"2","key":"10.1016\/j.ygyno.2021.02.004_bb0100","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.imlet.2006.09.005","article-title":"Exosomes: from biogenesis and secretion to biological function","volume":"107","author":"Keller","year":"2006","journal-title":"Immunol. Lett."},{"issue":"17","key":"10.1016\/j.ygyno.2021.02.004_bb0105","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1038\/emboj.2011.286","article-title":"Endosome maturation","volume":"30","author":"Huotari","year":"2011","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.ygyno.2021.02.004_bb0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrm2216","article-title":"Pathways of clathrin-independent endocytosis","volume":"8","author":"Mayor","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvj128","article-title":"Exosomes: a common pathway for a specialized function","volume":"140","author":"van Niel","year":"2006","journal-title":"J. Biochem."},{"issue":"6","key":"10.1016\/j.ygyno.2021.02.004_bb0120","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/emboj.2010.6","article-title":"VHS domains of ESCRT-0 cooperate in high-avidity binding to polyubiquitinated cargo","volume":"29","author":"Ren","year":"2010","journal-title":"EMBO J."},{"issue":"11","key":"10.1016\/j.ygyno.2021.02.004_bb0125","doi-asserted-by":"crossref","first-page":"10468","DOI":"10.1074\/jbc.M409969200","article-title":"Hrs, a mammalian master molecule in vesicular transport and protein sorting, suppresses the degradation of ESCRT proteins signal transducing adaptor molecule 1 and 2","volume":"280","author":"Kobayashi","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"Pt 24","key":"10.1016\/j.ygyno.2021.02.004_bb0130","first-page":"5553","article-title":"Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles","volume":"126","author":"Colombo","year":"2013","journal-title":"J. Cell Sci."},{"issue":"14","key":"10.1016\/j.ygyno.2021.02.004_bb0135","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1242\/dev.126516","article-title":"Exosomes in developmental signalling","volume":"143","author":"McGough","year":"2016","journal-title":"Develop. (Camb. Engl.)"},{"issue":"7235","key":"10.1016\/j.ygyno.2021.02.004_bb0140","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nature07836","article-title":"Membrane scission by the ESCRT-III complex","volume":"458","author":"Wollert","year":"2009","journal-title":"Nature."},{"issue":"30","key":"10.1016\/j.ygyno.2021.02.004_bb0145","doi-asserted-by":"crossref","first-page":"15753","DOI":"10.1074\/jbc.M116.718023","article-title":"The endosome-associated deubiquitinating enzyme USP8 regulates BACE1 enzyme ubiquitination and degradation","volume":"291","author":"Yeates","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ygyno.2021.02.004_bb0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell."},{"issue":"7","key":"10.1016\/j.ygyno.2021.02.004_bb0155","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: biogenesis, function and role in cancer","volume":"11","author":"Macfarlane","year":"2010","journal-title":"Curr. Genomics."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2004.12.031","article-title":"Phylogenetic shadowing and computational identification of human microRNA genes","volume":"120","author":"Berezikov","year":"2005","journal-title":"Cell."},{"issue":"4","key":"10.1016\/j.ygyno.2021.02.004_bb0165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.trsl.2011.01.007","article-title":"MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases","volume":"157","author":"Dai","year":"2011","journal-title":"Transl. Res."},{"issue":"7149","key":"10.1016\/j.ygyno.2021.02.004_bb0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nature05983","article-title":"Intronic microRNA precursors that bypass Drosha processing","volume":"448","author":"Ruby","year":"2007","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.ygyno.2021.02.004_bb0175","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cell.2006.07.031","article-title":"A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes","volume":"126","author":"Miranda","year":"2006","journal-title":"Cell."},{"issue":"12","key":"10.1016\/j.ygyno.2021.02.004_bb0180","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1261\/rna.7135204","article-title":"Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs","volume":"10","author":"Cai","year":"2004","journal-title":"RNA (New York, NY)"},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1479-7364-6-23","article-title":"An emerging role for microRNAs in NF1 tumorigenesis","volume":"6","author":"Sedani","year":"2012","journal-title":"Human Genom."},{"issue":"7051","key":"10.1016\/j.ygyno.2021.02.004_bb0190","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/nature03868","article-title":"TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing","volume":"436","author":"Chendrimada","year":"2005","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.ygyno.2021.02.004_bb0195","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/sj.bjc.6603023","article-title":"MicroRNAs in cell proliferation, cell death, and tumorigenesis","volume":"94","author":"Hwang","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"5858","key":"10.1016\/j.ygyno.2021.02.004_bb0200","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1126\/science.1149460","article-title":"Switching from repression to activation: microRNAs can up-regulate translation","volume":"318","author":"Vasudevan","year":"2007","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0205","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrm2080","article-title":"P bodies: at the crossroads of post-transcriptional pathways","volume":"8","author":"Eulalio","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"12","key":"10.1016\/j.ygyno.2021.02.004_bb0210","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/ncb1333","article-title":"A role for the P-body component GW182 in microRNA function","volume":"7","author":"Liu","year":"2005","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.ygyno.2021.02.004_bb0215","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/ncb1265","article-title":"Argonaute 2\/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies","volume":"7","author":"Sen","year":"2005","journal-title":"Nat. Cell Biol."},{"issue":"6","key":"10.1016\/j.ygyno.2021.02.004_bb0220","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1074\/jbc.M808788200","article-title":"Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype","volume":"284","author":"Davis","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ygyno.2021.02.004_bb0225","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1084\/jem.20121200","article-title":"VEGF controls lung Th2 inflammation via the miR-1-Mpl (myeloproliferative leukemia virus oncogene)-P-selectin axis","volume":"210","author":"Takyar","year":"2013","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.ygyno.2021.02.004_bb0230","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.3892\/mmr.2013.1713","article-title":"Canonical Wnt signaling activates miR-34 expression during osteoblastic differentiation","volume":"8","author":"Tamura","year":"2013","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.ygyno.2021.02.004_bb0235","first-page":"319","article-title":"Cervical cancer prevalence, incidence and mortality in low and middle income countries: a systematic review","volume":"19","author":"Shrestha","year":"2018","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"4","key":"10.1016\/j.ygyno.2021.02.004_bb0240","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2016.27.e43","article-title":"Advances in diagnosis and treatment of metastatic cervical cancer","volume":"27","author":"Li","year":"2016","journal-title":"J. Gynecol. Oncol."},{"issue":"10043","key":"10.1016\/j.ygyno.2021.02.004_bb0245","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0140-6736(15)01088-0","article-title":"Antiangiogenic therapy in oncology: current status and future directions","volume":"388","author":"Jayson","year":"2016","journal-title":"Lancet (Lond., Engl.)"},{"issue":"8","key":"10.1016\/j.ygyno.2021.02.004_bb0250","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMoa1309748","article-title":"Improved survival with bevacizumab in advanced cervical cancer","volume":"370","author":"Tewari","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ygyno.2021.02.004_bb0255","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1634\/theoncologist.2015-0393","article-title":"Clinical trials of antiangiogenesis therapy in recurrent\/persistent and metastatic cervical cancer","volume":"21","author":"Alldredge","year":"2016","journal-title":"Oncologist"},{"issue":"15","key":"10.1016\/j.ygyno.2021.02.004_bb0260","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S1470-2045(15)00220-X","article-title":"Cediranib combined with carboplatin and paclitaxel in patients with metastatic or recurrent cervical cancer (CIRCCa): a randomised, double-blind, placebo-controlled phase 2 trial","volume":"16","author":"Symonds","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0265","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/BST20120248","article-title":"Role of extracellular membrane vesicles in intercellular communication of the tumour microenvironment","volume":"41","author":"Svensson","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0270","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-015-0181-x","article-title":"Exosomes in cancer: small particle, big player","volume":"8","author":"Zhang","year":"2015","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0275","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13046-015-0148-3","article-title":"Signaling by exosomal microRNAs in cancer","volume":"34","author":"Falcone","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.ygyno.2021.02.004_bb0280","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1038\/s41419-017-0077-5","article-title":"MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2","volume":"8","author":"Wei","year":"2017","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.ygyno.2021.02.004_bb0285","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.bcp.2009.06.105","article-title":"Curcumin derivatives: molecular basis of their anti-cancer activity","volume":"78","author":"Basile","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"18","key":"10.1016\/j.ygyno.2021.02.004_bb0290","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1158\/0008-5472.CAN-16-0266","article-title":"Metabolic plasticity as a determinant of tumor growth and metastasis","volume":"76","author":"Lehu\u00e9d\u00e9","year":"2016","journal-title":"Cancer Res."},{"issue":"21","key":"10.1016\/j.ygyno.2021.02.004_bb0295","doi-asserted-by":"crossref","first-page":"7144","DOI":"10.1158\/1078-0432.CCR-03-0826","article-title":"High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer","volume":"10","author":"Bono","year":"2004","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.ygyno.2021.02.004_bb0300","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/modpathol.3800410","article-title":"Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes","volume":"18","author":"Dadras","year":"2005","journal-title":"Modern Pathol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.02.004_bb0305","first-page":"437","article-title":"Lymphatic microvessel density using D2-40 is associated with nodal metastasis in non-small cell lung cancer","volume":"15","author":"Takanami","year":"2006","journal-title":"Oncol. Rep."},{"issue":"7070","key":"10.1016\/j.ygyno.2021.02.004_bb0310","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04480","article-title":"Lymphangiogenesis in development and human disease","volume":"438","author":"Alitalo","year":"2005","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.ygyno.2021.02.004_bb0315","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ccr.2005.01.017","article-title":"Focus on lymphangiogenesis in tumor metastasis","volume":"7","author":"Achen","year":"2005","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.ygyno.2021.02.004_bb0320","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41388-018-0511-x","article-title":"Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymphangiogenesis and lymphatic metastasis by targeting VASH1","volume":"38","author":"Zhou","year":"2019","journal-title":"Oncogene."},{"issue":"1\u20132","key":"10.1016\/j.ygyno.2021.02.004_bb0325","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.drup.2012.01.008","article-title":"Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance","volume":"15","author":"Wilting","year":"2012","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ygyno.2021.02.004_bb0330","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.pharmtox.48.080907.180426","article-title":"The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy","volume":"48","author":"Hall","year":"2008","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.ygyno.2021.02.004_bb0335","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0163-7258(87)90009-X","article-title":"The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes","volume":"34","author":"Eastman","year":"1987","journal-title":"Pharmacol. Ther."},{"issue":"5868","key":"10.1016\/j.ygyno.2021.02.004_bb0340","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1126\/science.1140735","article-title":"An oncogene-induced DNA damage model for cancer development","volume":"319","author":"Halazonetis","year":"2008","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0345","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.mrgentox.2012.03.004","article-title":"Cisplatin treatment leads to changes in nuclear protein and microRNA expression","volume":"746","author":"Zhang","year":"2012","journal-title":"Mutat. Res."},{"issue":"6","key":"10.1016\/j.ygyno.2021.02.004_bb0350","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/bjc.1993.221","article-title":"Cellular accumulation of the anticancer agent cisplatin: a review","volume":"67","author":"Gately","year":"1993","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2021.02.004_bb0355","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00001813-199308000-00011","article-title":"Evidence of differential cisplatin-DNA adduct formation, removal and tolerance of DNA damage in three human lung carcinoma cell lines","volume":"4","author":"Shellard","year":"1993","journal-title":"Anti-Cancer Drugs"},{"issue":"5","key":"10.1016\/j.ygyno.2021.02.004_bb0360","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1158\/0008-5472.CAN-09-3112","article-title":"miR-181a and miR-630 regulate cisplatin-induced cancer cell death","volume":"70","author":"Galluzzi","year":"2010","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ygyno.2021.02.004_bb0365","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ijc.28500","article-title":"The network of P-glycoprotein and microRNAs interactions","volume":"135","author":"Lopes-Rodrigues","year":"2014","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.ygyno.2021.02.004_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095240","article-title":"Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ygyno.2021.02.004_bb0375","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/jcp.22773","article-title":"Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy","volume":"227","author":"Ciravolo","year":"2012","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.ygyno.2021.02.004_bb0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050999","article-title":"Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes","volume":"7","author":"Corcoran","year":"2012","journal-title":"PLoS One"},{"issue":"10\u221211","key":"10.1016\/j.ygyno.2021.02.004_bb0385","first-page":"1581","article-title":"Contribution of proteomics to understanding the role of tumor-derived exosomes in cancer progression: state of the art and new perspectives","volume":"13","author":"Fontana","year":"2013","journal-title":"Proteomics."},{"issue":"10","key":"10.1016\/j.ygyno.2021.02.004_bb0390","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1158\/1535-7163.MCT-05-0102","article-title":"Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells","volume":"4","author":"Safaei","year":"2005","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0395","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1096\/fj.11-186817","article-title":"Microparticle-associated nucleic acids mediate trait dominance in cancer","volume":"26","author":"Jaiswal","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0400","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cellsig.2017.07.005","article-title":"Horizontal transfer of miR-106a\/b from cisplatin resistant hepatocarcinoma cells can alter the sensitivity of cervical cancer cells to cisplatin","volume":"38","author":"Raji","year":"2017","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0405","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/ijms15010758","article-title":"Increased exosomal microRNA-21 and microRNA-146a levels in the cervicovaginal lavage specimens of patients with cervical cancer","volume":"15","author":"Liu","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ygyno.2021.02.004_bb0410","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1615\/CritRevEukaryotGeneExpr.2019025273","article-title":"MicroRNAs as diagnostic, prognostic, and therapeutic biomarkers in prostate cancer","volume":"29","author":"Aghdam","year":"2019","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"issue":"3","key":"10.1016\/j.ygyno.2021.02.004_bb0415","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10456-019-09665-1","article-title":"Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma","volume":"22","author":"Wu","year":"2019","journal-title":"Angiogenesis."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0420","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12943-019-0999-x","article-title":"Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors","volume":"18","author":"Zheng","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ygyno.2021.02.004_bb0425","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pdpdt.2018.08.006","article-title":"ALA-PDT promotes HPV-positive cervical cancer cells apoptosis and DCs maturation via miR-34a regulated HMGB1 exosomes secretion","volume":"24","author":"Jin","year":"2018","journal-title":"Photodiagn. Photodyn. Ther."},{"issue":"3","key":"10.1016\/j.ygyno.2021.02.004_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004712","article-title":"Dependence of intracellular and exosomal microRNAs on viral E6\/E7 oncogene expression in HPV-positive tumor cells","volume":"11","author":"Honegger","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0435","doi-asserted-by":"crossref","first-page":"10307","DOI":"10.2147\/CMAR.S221527","article-title":"Cervical cancer cells-secreted exosomal microRNA-221-3p promotes invasion, migration and angiogenesis of microvascular endothelial cells in cervical cancer by down-regulating MAPK10 expression","volume":"11","author":"Zhang","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"11","key":"10.1016\/j.ygyno.2021.02.004_bb0440","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1002\/1878-0261.12371","article-title":"Exosomal microRNAs as tumor markers in epithelial ovarian cancer","volume":"12","author":"Pan","year":"2018","journal-title":"Mol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.02.004_bb0445","first-page":"3376","article-title":"Identification of exosomal and non-exosomal microRNAs associated with the drug resistance of ovarian cancer","volume":"19","author":"Feng","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0450","doi-asserted-by":"crossref","first-page":"11150","DOI":"10.1038\/ncomms11150","article-title":"Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1","volume":"7","author":"Au Yeung","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0455","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ebiom.2018.11.004","article-title":"Exosomal miRNA confers chemo resistance via targeting Cav1\/p-gp\/M2-type macrophage axis in ovarian cancer","volume":"38","author":"Kanlikilicer","year":"2018","journal-title":"EBioMedicine."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0460","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1186\/s12885-018-4974-5","article-title":"Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells","volume":"18","author":"Yoshimura","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ygyno.2021.02.004_bb0465","series-title":"Exosomal Transfer of Stroma-Derived miR21 Confers Paclitaxel Resistance in Ovarian Cancer Cells through Targeting APAF1","first-page":"11150","volume":"7","author":"Au Yeung","year":"2016"},{"issue":"24","key":"10.1016\/j.ygyno.2021.02.004_bb0470","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1158\/0008-5472.CAN-16-0714","article-title":"Ubiquitous release of exosomal tumor suppressor miR-6126 from ovarian cancer cells","volume":"76","author":"Kanlikilicer","year":"2016","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.ygyno.2021.02.004_bb0475","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1158\/2326-6066.CIR-17-0479","article-title":"Exosomes released from tumor-associated macrophages transfer miRNAs that induce a Treg\/Th17 cell imbalance in epithelial ovarian cancer","volume":"6","author":"Zhou","year":"2018","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0480","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13048-018-0477-x","article-title":"Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer","volume":"12","author":"Su","year":"2019","journal-title":"J. Ovarian Res."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0485","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13046-019-1095-1","article-title":"Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype","volume":"38","author":"Zhu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0490","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2008.04.033","article-title":"MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer","volume":"110","author":"Taylor","year":"2008","journal-title":"Gynecol. Oncol."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0495","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13048-018-0458-0","article-title":"Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types","volume":"11","author":"Kobayashi","year":"2018","journal-title":"Journal of ovarian research."},{"issue":"4","key":"10.1016\/j.ygyno.2021.02.004_bb0500","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.amjms.2019.07.005","article-title":"The value of plasma-based MicroRNAs as diagnostic biomarkers for ovarian cancer","volume":"358","author":"Wang","year":"2019","journal-title":"Am J Med Sci"},{"issue":"13","key":"10.1016\/j.ygyno.2021.02.004_bb0505","doi-asserted-by":"crossref","first-page":"16923","DOI":"10.18632\/oncotarget.7850","article-title":"Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer","volume":"7","author":"Meng","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0510","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1479-5876-12-4","article-title":"Ovarian cancer cell invasiveness is associated with discordant exosomal sequestration of Let-7 miRNA and miR-200","volume":"12","author":"Kobayashi","year":"2014","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0515","doi-asserted-by":"crossref","first-page":"522","DOI":"10.3892\/or.2017.5697","article-title":"Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization","volume":"38","author":"Chen","year":"2017","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0520","first-page":"256","article-title":"Downregulation of miR-145-5p in cancer cells and their derived exosomes may contribute to the development of ovarian cancer by targeting CT","volume":"43","author":"Hang","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"9","key":"10.1016\/j.ygyno.2021.02.004_bb0525","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1093\/carcin\/bgu130","article-title":"Exosome-derived miRNAs and ovarian carcinoma progression","volume":"35","author":"Vaksman","year":"2014","journal-title":"Carcinogenesis."},{"issue":"12","key":"10.1016\/j.ygyno.2021.02.004_bb0530","doi-asserted-by":"crossref","first-page":"20145","DOI":"10.18632\/oncotarget.15525","article-title":"Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs","volume":"8","author":"Rashed","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0535","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2017.02.009","article-title":"TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA","volume":"393","author":"Hu","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0540","series-title":"Exosomes Released from M2 Macrophages Transfer miR-221-3p Contributed to EOC Progression through Targeting CDKN1B","author":"Li","year":"2020"},{"issue":"26","key":"10.1016\/j.ygyno.2021.02.004_bb0545","doi-asserted-by":"crossref","first-page":"8206","DOI":"10.7150\/thno.37455","article-title":"Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis","volume":"9","author":"He","year":"2019","journal-title":"Theranostics."},{"issue":"28","key":"10.1016\/j.ygyno.2021.02.004_bb0550","doi-asserted-by":"crossref","first-page":"43076","DOI":"10.18632\/oncotarget.9246","article-title":"Epithelial ovarian cancer-secreted exosomal miR-222-3p induces polarization of tumor-associated macrophages","volume":"7","author":"Ying","year":"2016","journal-title":"Oncotarget."},{"issue":"9","key":"10.1016\/j.ygyno.2021.02.004_bb0555","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.7150\/jca.30231","article-title":"Serum exosomal miRNA-145 and miRNA-200c as promising biomarkers for preoperative diagnosis of ovarian carcinomas","volume":"10","author":"Kim","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.ygyno.2021.02.004_bb0560","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12935-019-0990-z","article-title":"Exosomal microRNA-205 is involved in proliferation, migration, invasion, and apoptosis of ovarian cancer cells via regulating VEGFA","volume":"19","author":"Wang","year":"2019","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.ygyno.2021.02.004_bb0565","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/CBM-191123","article-title":"Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer","volume":"27","author":"Zhang","year":"2020","journal-title":"Cancer Biomark."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0570","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13048-020-00648-1","article-title":"Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer","volume":"13","author":"Maeda","year":"2020","journal-title":"J. Ovarian Res."},{"issue":"3","key":"10.1016\/j.ygyno.2021.02.004_bb0575","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1002\/jcp.27111","article-title":"Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.ygyno.2021.02.004_bb0580","article-title":"MiR-130a and MiR-374a function as novel regulators of cisplatin resistance in human ovarian cancer A2780 cells","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ygyno.2021.02.004_bb0585","first-page":"1357","article-title":"Downregulation of miR-429 contributes to the development of drug resistance in epithelial ovarian cancer by targeting ZEB1","volume":"9","author":"Zou","year":"2017","journal-title":"Am. J. Transl. Res."},{"issue":"12","key":"10.1016\/j.ygyno.2021.02.004_bb0590","first-page":"2526","article-title":"Evidence for miR-17-92 and miR-134 gene cluster regulation of ovarian cancer drug resistance","volume":"20","author":"Zhu","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"42","key":"10.1016\/j.ygyno.2021.02.004_bb0595","doi-asserted-by":"crossref","first-page":"72788","DOI":"10.18632\/oncotarget.20348","article-title":"miR-150 enhances apoptotic and anti-tumor effects of paclitaxel in paclitaxel-resistant ovarian cancer cells by targeting Notch3","volume":"8","author":"Kim","year":"2017","journal-title":"Oncotarget."},{"issue":"2","key":"10.1016\/j.ygyno.2021.02.004_bb0600","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrc2067","article-title":"The tumour microenvironment as a target for chemoprevention","volume":"7","author":"Albini","year":"2007","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0605","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1158\/1541-7786.MCR-16-0191","article-title":"Exosomes promote ovarian cancer cell invasion through transfer of CD44 to peritoneal mesothelial cells","volume":"15","author":"Nakamura","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0610","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1038\/ncomms14470","article-title":"Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer","volume":"8","author":"Yokoi","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0615","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ygyno.2016.03.036","article-title":"The biological significance and clinical applications of exosomes in ovarian cancer","volume":"142","author":"Dorayappan","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.02.004_bb0620","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3892\/ijo.2017.3948","article-title":"MicroRNAs driving invasion and metastasis in ovarian cancer: opportunities for translational medicine (review)","volume":"50","author":"Palma Flores","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.02.004_bb0625","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1002\/jcp.27111","article-title":"Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.ygyno.2021.02.004_bb0630","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1208\/s12248-018-0220-y","article-title":"A non-invasive liquid biopsy screening of urine-derived exosomes for miRNAs as biomarkers in endometrial cancer patients","volume":"20","author":"Srivastava","year":"2018","journal-title":"AAPS J."},{"issue":"13","key":"10.1016\/j.ygyno.2021.02.004_bb0635","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00018-016-2174-5","article-title":"Mechanisms of long noncoding RNA function in development and disease","volume":"73","author":"Schmitz","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0640","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7202\/1040911ar","article-title":"Pr\u00e9sentation","volume":"43","author":"Delas","year":"2017","journal-title":"\u00c9tudes Litt\u00e9raires Africaines."},{"issue":"2","key":"10.1016\/j.ygyno.2021.02.004_bb0645","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.cmet.2016.11.016","article-title":"Human pancreatic \u03b2 cell lncRNAs control cell-specific regulatory networks","volume":"25","author":"Akerman","year":"2017","journal-title":"Cell Metab."},{"issue":"4","key":"10.1016\/j.ygyno.2021.02.004_bb0650","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cmet.2012.08.010","article-title":"Human \u03b2 cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes","volume":"16","author":"Mor\u00e1n","year":"2012","journal-title":"Cell Metab."},{"issue":"8","key":"10.1016\/j.ygyno.2021.02.004_bb0655","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.tig.2017.05.004","article-title":"The diversity of long noncoding RNAs and their generation","volume":"33","author":"Wu","year":"2017","journal-title":"Trends Genet."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0660","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cell.2014.09.005","article-title":"Biogenesis of circular RNAs","volume":"159","author":"Vicens","year":"2014","journal-title":"Cell."},{"issue":"4","key":"10.1016\/j.ygyno.2021.02.004_bb0665","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrm.2015.32","article-title":"The biogenesis and emerging roles of circular RNAs","volume":"17","author":"Chen","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.ygyno.2021.02.004_bb0670","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4161\/rna.23547","article-title":"Paraspeckle formation during the biogenesis of long non-coding RNAs","volume":"10","author":"Naganuma","year":"2013","journal-title":"RNA Biol."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0675","first-page":"1","article-title":"The building process of the functional paraspeckle with long non-coding RNAs","volume":"7","author":"Yamazaki","year":"2015","journal-title":"Front. Biosci. (Elite Ed.)"},{"issue":"10","key":"10.1016\/j.ygyno.2021.02.004_bb0680","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nsmb.3479","article-title":"Paraspeckles: nuclear nests helping to raise mature miRNAs","volume":"24","author":"Krol","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0685","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4939-3378-5_2","article-title":"Cross-linking immunoprecipitation and qPCR (CLIP-qPCR) analysis to map interactions between long noncoding RNAs and RNA-Binding Proteins","volume":"1402","author":"Yoon","year":"2016","journal-title":"Methods Mol. Biol. (Clifton, NJ)"},{"issue":"12","key":"10.1016\/j.ygyno.2021.02.004_bb0690","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1111\/jcmm.13238","article-title":"State of the art technologies to explore long non-coding RNAs in cancer","volume":"21","author":"Salehi","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0695","first-page":"88","article-title":"Discovery of protein-lncRNA interactions by integrating large-scale CLIP-Seq and RNA-Seq datasets","volume":"2","author":"Li","year":"2014","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"43","key":"10.1016\/j.ygyno.2021.02.004_bb0700","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1038\/onc.2011.621","article-title":"Long non-coding RNAs and cancer: a new frontier of translational research?","volume":"31","author":"Spizzo","year":"2012","journal-title":"Oncogene."},{"issue":"7291","key":"10.1016\/j.ygyno.2021.02.004_bb0705","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","article-title":"Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature."},{"issue":"7","key":"10.1016\/j.ygyno.2021.02.004_bb0710","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1158\/0008-5472.CAN-14-2931","article-title":"Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205","volume":"75","author":"Hirata","year":"2015","journal-title":"Cancer Res."},{"issue":"39","key":"10.1016\/j.ygyno.2021.02.004_bb0715","doi-asserted-by":"crossref","first-page":"65253","DOI":"10.18632\/oncotarget.18224","article-title":"Long non-coding RNA TUG1 promotes cervical cancer progression by regulating the miR-138-5p-SIRT1 axis","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget."},{"issue":"2","key":"10.1016\/j.ygyno.2021.02.004_bb0720","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/cam4.994","article-title":"Upregulation of long noncoding RNA TUG1 promotes cervical cancer cell proliferation and migration","volume":"6","author":"Hu","year":"2017","journal-title":"Cancer Med."},{"issue":"8","key":"10.1016\/j.ygyno.2021.02.004_bb0725","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/15384047.2020.1764318","article-title":"Exosomal taurine up-regulated 1 promotes angiogenesis and endothelial cell proliferation in cervical cancer","volume":"21","author":"Lei","year":"2020","journal-title":"Cancer Biol. Therapy."},{"issue":"10","key":"10.1016\/j.ygyno.2021.02.004_bb0730","doi-asserted-by":"crossref","first-page":"8481","DOI":"10.1002\/jcb.27074","article-title":"LncRNA FAL1 is a negative prognostic biomarker and exhibits pro-oncogenic function in osteosarcoma","volume":"119","author":"Wang","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.ygyno.2021.02.004_bb0735","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s12013-015-0671-z","article-title":"High levels of phosphatase and tensin homolog expression predict favorable prognosis in patients with non-small cell lung Cancer","volume":"73","author":"Li","year":"2015","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0740","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13039-017-0348-y","article-title":"Distinct subtypes of genomic PTEN deletion size influence the landscape of aneuploidy and outcome in prostate cancer","volume":"11","author":"Vidotto","year":"2018","journal-title":"Mol. Cytogenet."},{"issue":"5","key":"10.1016\/j.ygyno.2021.02.004_bb0745","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1634\/theoncologist.2013-0333","article-title":"The role of the PTEN\/PI3K\/Akt pathway on prognosis in epithelial ovarian cancer: a meta-analysis","volume":"19","author":"Cai","year":"2014","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0750","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20176472","article-title":"Exosomes promote cetuximab resistance via the PTEN\/Akt pathway in colon cancer cells","volume":"51","author":"Zhang","year":"2017","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0755","first-page":"43","article-title":"Exosomes transferring long non-coding RNA FAL1 to regulate ovarian cancer metastasis through the PTEN\/AKT signaling pathway","volume":"24","author":"Zhang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.ygyno.2021.02.004_bb0760","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00432-015-2042-y","article-title":"Urothelial cancer associated 1: a long noncoding RNA with a crucial role in cancer","volume":"142","author":"Xue","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ygyno.2021.02.004_bb0765","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/cas.13058","article-title":"Long non-coding RNA UCA1 contributes to the progression of oral squamous cell carcinoma by regulating the WNT\/\u03b2-catenin signaling pathway","volume":"107","author":"Yang","year":"2016","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.ygyno.2021.02.004_bb0770","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2015.11.024","article-title":"LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p","volume":"371","author":"Nie","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0775","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtn.2019.05.007","article-title":"lncRNA UCA1 mediates resistance to cisplatin by regulating the miR-143\/FOSL2-signaling pathway in ovarian cancer","volume":"17","author":"Li","year":"2019","journal-title":"Mol. Therapy Nucl. Acids."},{"issue":"7","key":"10.1016\/j.ygyno.2021.02.004_bb0780","article-title":"Appraising the value of serum and serum-derived exosomal LncRNA-EXOC7 as a promising biomarker in cervical cancer","volume":"66","author":"Guo","year":"2020","journal-title":"Clin. Lab."},{"key":"10.1016\/j.ygyno.2021.02.004_bb0785","series-title":"Exosomal lncRNA HNF1A-AS1 Affects Cisplatin Resistance in Cervical Cancer Cells Through Regulating MicroRNA-34b\/TUFT1 Axis","first-page":"323","volume":"19","author":"Luo","year":"2019"},{"issue":"7, Supplement","key":"10.1016\/j.ygyno.2021.02.004_bb0790","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jmig.2019.09.044","article-title":"Exosomal long noncoding RNA-NONHAT076754 faciliates endometriosis invasion and predicts endometriosis recurrence","volume":"26","author":"Qiu","year":"2019","journal-title":"J. Minim. Invasive Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821001402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821001402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:55:32Z","timestamp":1758772532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821001402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":158,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0090825821001402"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.02.004","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2021.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}